Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hindi

Showing results (691-700 of 722) with videos related to

Pageof 73
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC TrialDavid S Moura, Jesus M Lopez-Marti, Iva Benesova, et al.
Cancer Communications (London, England)|March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma CohortJavier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Annals of Surgical Oncology|April 17, 2026
First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
Cancer Immunology Research|September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor ImmunityHelen Kotanides, Yiwen Li, Maria Malabunga, et al.
The Lancet Regional Health. Europe|February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACANJean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
The Lancet. Oncology|December 23, 2018
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, et al.
Cancer Medicine|March 13, 2021
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literatureAnna M Frezza, Vinod Ravi, Salvatore Lo Vullo, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
Pageof 73

Showing results (691-700 of 722) with videos related to

Sort By:
Pageof 73
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC TrialDavid S Moura, Jesus M Lopez-Marti, Iva Benesova, et al.
Cancer Communications (London, England)|March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma CohortJavier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Annals of Surgical Oncology|April 17, 2026
First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
Cancer Immunology Research|September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor ImmunityHelen Kotanides, Yiwen Li, Maria Malabunga, et al.
The Lancet Regional Health. Europe|February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACANJean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
The Lancet. Oncology|December 23, 2018
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, et al.
Cancer Medicine|March 13, 2021
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literatureAnna M Frezza, Vinod Ravi, Salvatore Lo Vullo, et al.
The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
Pageof 73